LeePR. The Task Force on Prescription Drugs: A review of problems, progress, and possibilities. J Res Pharmaceutical Economics. 2001;10:183–191.
2.
EpsteinEAHallstromAPRogersWJ, Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA. 1993;270:2451–2455.
3.
MukherjeeDNissenSETopolEJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286:954–959.
4.
StreinerDL. (2003). Unicorns do exist: A tutorial on “proving” the null hypothesis. Can J Psychiatry. 2003;48:756–761.